LIMINATUS PHARMA INC.
CL A · CUSIP 53271X108
15
institutional holders
+3 vs Q4 2025
1.5m
shares reported held*
$253.8kreported value*
4 new
5 added
3 reduced
2 sold out
net bought ≈ $199.1k (+1.2m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.17.
Trends to Q1 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2025 | 10 |
| Q3 2025 | 10 |
| Q4 2025 | 12 |
| Q1 2026 | 15 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2025 | 6 | 4 |
| Q4 2025 | 6 | 4 |
| Q1 2026 | 9 | 5 |
Biggest buyers
| CITADEL ADVISORS LLC | Added | +606.6k |
| Cygnus Capital Advisors, LLC | New | +350.0k |
| JANE STREET GROUP, LLC | New | +71.3k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +52.7k |
| UBS Group AG | Added | +35.2k |
| Vanguard Personalized Indexing Management, LLC | New | +34.7k |
| Virtu Financial LLC | New | +27.5k |
| TWO SIGMA SECURITIES, LLC | Added | +10.2k |
| CITIGROUP INC | Added | +6.8k |
Biggest sellers
| TWO SIGMA INVESTMENTS, LP | Sold out | -35.3k |
| Tower Research Capital LLC (TRC) | Reduced | -1.3k |
| BANK OF AMERICA CORP /DE/ | Sold out | -44 |
| Farther Finance Advisors, LLC | Reduced | -17 |
| BlackRock, Inc. | Reduced | -1 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Iris Acquisition Holdings LLC
13D · may seek influence
new · filed 2025-05-08
Stated purposeTo the extent required by Item 4, the information set forth in Item 3 and Item 6 of this Schedule 13D is incorporated herein by reference. The Reporting Person does not have any present plan or proposal that would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Person acquired the shares of common stock reported herein as beneficially owned by the Reporting Person solely for investment purposes and in connection with the business combination described herein. The Reporting Person intends to review their investment in the Issuer on a continuing basis. Depending on various facto… Full filing |
26.5% |
| KH Feelux Co., Ltd 13G · passive investor new · filed 2025-06-27 | 15.4% |
Valetudo Therapeutics LLC
13D · may seek influence
-9.4 pts · filed 2026-07-14
Stated purposeThe information set forth in Item 3 above is incorporated into this Item 4 by reference. The Reporting Persons may acquire additional securities of the Issuer, or retain or sell all or a portion of the securities then held, in the open market or in privately negotiated transactions. Chris Kim serves as Chief Executive Officer and a director of the Issuer, and, in such capacity, may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Except as described in this Statement, each of the Reporting Person does not have any present plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, ex… Full filing |
14.3% |
| Ewon Comfortech Co., Ltd. 13G · passive investor +5.1 pts · filed 2026-07-06 | 10.9% |
| Nongae Apple Association 1st 13G · passive investor new · filed 2025-06-26 | 5.7% |
| Red Peony Association 1st 13G · passive investor new · filed 2025-06-26 | 5.7% |
| Samda Biolab Co., Ltd. 13G · passive investor new · filed 2026-07-22 | 5.1% |
Fell to 5% or below in the last year: INTRACOASTAL CAPITAL, LLC (5.0%, 2026-02-20)
Holders, Q1 2026
| Manager | Shares | Change |
|---|---|---|
| CITADEL ADVISORS LLC 0.00% of their portfolio | 677.5k $116.5k | Added +606.6k |
| Cygnus Capital Advisors, LLC 0.04% of their portfolio | 350.0k $60.0k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 117.8k $20.2k | Added +52.7k |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 71.3k $12.3k | New |
| UBS Group AG 0.00% of their portfolio | 54.6k $9.4k | Added +35.2k |
| VANGUARD CAPITAL MANAGEMENT LLC 0.00% of their portfolio | 50.4k $8.7k | First filing |
| Vanguard Personalized Indexing Management, LLC 0.00% of their portfolio | 34.7k $6.0k | New |
| Virtu Financial LLC 0.00% of their portfolio | 27.5k $5.0k | New |
| VANGUARD FIDUCIARY TRUST CO 0.00% of their portfolio | 23.0k $4.0k | First filing |
| TWO SIGMA SECURITIES, LLC 0.00% of their portfolio | 22.0k $3.8k | Added +10.2k |
| STATE STREET CORP 0.00% of their portfolio | 19.0k $3.3k | Unchanged |
| BlackRock, Inc. 0.00% of their portfolio | 13.3k $2.3k | Reduced -1 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 7.6k $1.3k | Reduced -1.3k |
| CITIGROUP INC 0.00% of their portfolio | 6.8k $1.2k | Added +6.8k |
| Farther Finance Advisors, LLC 0.00% of their portfolio | 14 $2 | Reduced -17 |